ATAIBECKLEY INC (9VC.DE) Fundamental Analysis & Valuation
FRA:9VC • NL0015000DX5
Current stock price
3.426 EUR
-0.04 (-1.21%)
Last:
This 9VC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 9VC.DE Profitability Analysis
1.1 Basic Checks
- In the past year 9VC has reported negative net income.
- 9VC had a negative operating cash flow in the past year.
- In the past 5 years 9VC always reported negative net income.
- 9VC had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -62.24%, 9VC is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of -93.44%, 9VC is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.24% | ||
| ROE | -93.44% | ||
| ROIC | N/A |
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- 9VC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. 9VC.DE Health Analysis
2.1 Basic Checks
- 9VC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for 9VC has been increased compared to 1 year ago.
- Compared to 5 years ago, 9VC has more shares outstanding
- 9VC has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 5.29 indicates that 9VC is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 5.29, 9VC is doing good in the industry, outperforming 76.36% of the companies in the same industry.
- There is no outstanding debt for 9VC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.29 |
ROIC/WACCN/A
WACC7.43%
2.3 Liquidity
- 9VC has a Current Ratio of 7.90. This indicates that 9VC is financially healthy and has no problem in meeting its short term obligations.
- 9VC's Current ratio of 7.90 is amongst the best of the industry. 9VC outperforms 98.18% of its industry peers.
- 9VC has a Quick Ratio of 7.90. This indicates that 9VC is financially healthy and has no problem in meeting its short term obligations.
- 9VC's Quick ratio of 7.90 is amongst the best of the industry. 9VC outperforms 98.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.9 | ||
| Quick Ratio | 7.9 |
3. 9VC.DE Growth Analysis
3.1 Past
- The earnings per share for 9VC have decreased by 0.00% in the last year.
- Looking at the last year, 9VC shows a decrease in Revenue. The Revenue has decreased by -1.91% in the last year.
- The Revenue for 9VC have been decreasing by -75.28% on average. This is quite bad
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%
3.2 Future
- 9VC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.08% yearly.
- 9VC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 234.05% yearly.
EPS Next Y30.67%
EPS Next 2Y22.22%
EPS Next 3Y14.8%
EPS Next 5Y14.08%
Revenue Next Year468.25%
Revenue Next 2Y-38.09%
Revenue Next 3Y24.11%
Revenue Next 5Y234.05%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. 9VC.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for 9VC. In the last year negative earnings were reported.
- Also next year 9VC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- 9VC's earnings are expected to grow with 14.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.22%
EPS Next 3Y14.8%
5. 9VC.DE Dividend Analysis
5.1 Amount
- 9VC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
9VC.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:9VC (12/30/2025, 7:00:00 PM)
3.426
-0.04 (-1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-16 2026-03-16/amc
Inst Owners12.45%
Inst Owner ChangeN/A
Ins Owners3.7%
Ins Owner ChangeN/A
Market Cap1.24B
Revenue(TTM)308.00K
Net Income(TTM)-149.27M
Analysts83.33
Price Target10.49 (206.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-74.59%
Min EPS beat(2)-131.54%
Max EPS beat(2)-17.64%
EPS beat(4)1
Avg EPS beat(4)-48.58%
Min EPS beat(4)-131.54%
Max EPS beat(4)17.15%
EPS beat(8)3
Avg EPS beat(8)-34.15%
EPS beat(12)6
Avg EPS beat(12)-5.69%
EPS beat(16)8
Avg EPS beat(16)-13.8%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.74%
PT rev (3m)7.46%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.5%
Revenue NQ rev (1m)-11.11%
Revenue NQ rev (3m)18.52%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)29.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4703.25 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 9.07 | ||
| P/tB | 9.26 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS0.38
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.24% | ||
| ROE | -93.44% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1203.88% | ||
| Cap/Sales | 3521.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.9 | ||
| Quick Ratio | 7.9 | ||
| Altman-Z | 5.29 |
F-Score4
WACC7.43%
ROIC/WACCN/A
Cap/Depr(3y)268.35%
Cap/Depr(5y)673.01%
Cap/Sales(3y)220.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y30.67%
EPS Next 2Y22.22%
EPS Next 3Y14.8%
EPS Next 5Y14.08%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%
Revenue Next Year468.25%
Revenue Next 2Y-38.09%
Revenue Next 3Y24.11%
Revenue Next 5Y234.05%
EBIT growth 1Y18.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-5.8%
EBIT Next 3Y-18.5%
EBIT Next 5Y-6.5%
FCF growth 1Y3.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.22%
OCF growth 3YN/A
OCF growth 5YN/A
ATAIBECKLEY INC / 9VC.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ATAIBECKLEY INC (9VC.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to 9VC.DE.
What is the valuation status for 9VC stock?
ChartMill assigns a valuation rating of 0 / 10 to ATAIBECKLEY INC (9VC.DE). This can be considered as Overvalued.
How profitable is ATAIBECKLEY INC (9VC.DE) stock?
ATAIBECKLEY INC (9VC.DE) has a profitability rating of 0 / 10.